118 related articles for article (PubMed ID: 2752912)
1. Stability of dactimicin to aminoglycoside-modifying enzymes produced by 341 bacterial clinical isolates.
Gómez-Lus R; Gómez-Lus S; Goñi MP; Rivera MJ; Martín C; Rubio-Calvo MC
Drugs Exp Clin Res; 1989; 15(3):129-32. PubMed ID: 2752912
[TBL] [Abstract][Full Text] [Related]
2. Stability of dactimicin to aminoglycoside-modifying enzymes.
Gomez-Lus R; Marco MA; Gomez-Lus ML
Drugs Exp Clin Res; 1987; 13(12):731-5. PubMed ID: 3447876
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
Felmingham D; Jones K
Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
[TBL] [Abstract][Full Text] [Related]
4. Prodigious substrate specificity of AAC(6')-APH(2"), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci.
Daigle DM; Hughes DW; Wright GD
Chem Biol; 1999 Feb; 6(2):99-110. PubMed ID: 10021417
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and mechanisms of amikacin resistance and its association with beta-lactamases in Pseudomonas aeruginosa: a Korean nationwide study.
Kim JY; Park YJ; Kwon HJ; Han K; Kang MW; Woo GJ
J Antimicrob Chemother; 2008 Sep; 62(3):479-83. PubMed ID: 18606785
[TBL] [Abstract][Full Text] [Related]
6. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
Miller GH; Sabatelli FJ; Naples L; Hare RS; Shaw KJ
J Chemother; 1995 Jun; 7 Suppl 2():31-44. PubMed ID: 8622109
[TBL] [Abstract][Full Text] [Related]
7. Detection by polymerase chain reaction of genes encoding aminoglycoside-modifying enzymes in methicillin-resistant Staphylococcus aureus isolates of epidemic phage types. Belgian Study Group of Hospital Infections (GDEPIH/GOSPIZ).
Vanhoof R; Godard C; Content J; Nyssen HJ; Hannecart-Pokorni E
J Med Microbiol; 1994 Oct; 41(4):282-90. PubMed ID: 7932622
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of genes encoding aminoglycoside-modifying enzymes among meticillin-resistant Staphylococcus aureus isolated from two hospitals in Tehran, Iran.
Fatholahzadeh B; Emaneini M; Feizabadi MM; Sedaghat H; Aligholi M; Taherikalani M; Jabalameli F
Int J Antimicrob Agents; 2009 Mar; 33(3):264-5. PubMed ID: 19084382
[TBL] [Abstract][Full Text] [Related]
9. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
Omoto S; Yoshida T; Kurebe M; Inouye S
Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical and genetic mechanisms for bacteria to acquire aminoglycoside antibiotic resistance].
Hotta K
Nihon Rinsho; 1997 May; 55(5):1231-7. PubMed ID: 9155180
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of dactimicin, a novel pseudodisaccharide aminoglycoside, compared with activities of other aminoglycosides.
Gu JW; Neu HC
Antimicrob Agents Chemother; 1989 Nov; 33(11):1998-2003. PubMed ID: 2514625
[TBL] [Abstract][Full Text] [Related]
12. The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups.
J Chemother; 1995 Jun; 7 Suppl 2():17-30. PubMed ID: 8622108
[TBL] [Abstract][Full Text] [Related]
13. Domain-domain interactions in the aminoglycoside antibiotic resistance enzyme AAC(6')-APH(2'').
Boehr DD; Daigle DM; Wright GD
Biochemistry; 2004 Aug; 43(30):9846-55. PubMed ID: 15274639
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside resistance patterns in clinical isolates of E. coli and Klebsiella sp. from Czechoslovakia and the United States.
Navarová J; Kettner K; Krcméry V; Folrichová D
J Hyg Epidemiol Microbiol Immunol; 1989; 33(4):477-86. PubMed ID: 2696761
[TBL] [Abstract][Full Text] [Related]
15. A survey of clinical isolates of Enterobacteriaceae using a series of DNA probes for aminoglycoside resistance genes.
Flamm RK; Phillips KL; Tenover FC; Plorde JJ
Mol Cell Probes; 1993 Apr; 7(2):139-44. PubMed ID: 8391641
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.
Schmitz FJ; Fluit AC; Gondolf M; Beyrau R; Lindenlauf E; Verhoef J; Heinz HP; Jones ME
J Antimicrob Chemother; 1999 Feb; 43(2):253-9. PubMed ID: 11252331
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of vertilmicin to modifications by three types of recombinant aminoglycoside-modifying enzymes.
Yuan M; Han H; Li CR; Yang XY; Li GQ; Cen S; Kang XX; Si SY; Jiang JD; You XF
Antimicrob Agents Chemother; 2011 Aug; 55(8):3950-3. PubMed ID: 21646489
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the bifunctional aminoglycoside-modifying enzyme ANT(3'')-Ii/AAC(6')-IId from Serratia marcescens.
Kim C; Hesek D; Zajícek J; Vakulenko SB; Mobashery S
Biochemistry; 2006 Jul; 45(27):8368-77. PubMed ID: 16819836
[TBL] [Abstract][Full Text] [Related]
19. Role of the acetyltransferase AAC(6')-Iz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia.
Li XZ; Zhang L; McKay GA; Poole K
J Antimicrob Chemother; 2003 Apr; 51(4):803-11. PubMed ID: 12654758
[TBL] [Abstract][Full Text] [Related]
20. [The propagation of aminoglycoside transferases in gram negative bacteria].
Wiedemann B; Tetzlaff G; van Treeck U
Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):138-44. PubMed ID: 429085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
